📰 Opgen News
Opgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Opgen. Real-time updates on events, politics, business and more.
May 4, 2024
StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Wednesday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN opened at $0.47 on Wednesday. The company’s 50-day simple moving average is $0.57 and its 200-day simple moving […]
May 4, 2024
StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Trading Down 3.1 % OPGN opened at $0.47 on Wednesday. The company has a market capitalization of $5.93 million, a price-to-earnings ratio […]
April 11, 2024
OpGen, Inc. (NASDAQ:OPGN – Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 2,230,000 shares, an increase of 10,621.2% from the March 15th total of 20,800 shares. Based on an average daily trading volume, of 1,670,000 shares, the short-interest ratio is currently 1.3 […]
March 28, 2024
OpGen, Inc. (NASDAQ:OPGN – Get Free Report) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 20,800 shares, a drop of 47.3% from the February 29th total of 39,500 shares. Based on an average daily trading volume, of 1,470,000 shares, the short-interest ratio […]
March 23, 2024
HC Wainwright reaffirmed their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a report issued on Wednesday, Benzinga reports. HC Wainwright currently has a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, Q3 […]
February 8, 2024
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued on Tuesday. Precigen Stock Performance NASDAQ PGEN opened at $1.38 on Tuesday. The company’s fifty day moving average is $1.30 and its two-hundred day moving average is $1.32. Precigen has a 52-week low […]
February 8, 2024
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by stock analysts at StockNews.com to a “sell” rating in a research report issued on Tuesday. Precigen Price Performance Shares of PGEN opened at $1.38 on Tuesday. The firm has a fifty day simple moving average of $1.30 and a two-hundred day simple moving average of $1.32. […]
January 28, 2024
Equities researchers at StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the medical research company’s stock. OpGen Stock Up 4.8 % OPGN traded up $0.02 on Thursday, hitting $0.35. 81,961 shares of the […]
January 23, 2024
Magnolia Capital Advisors LLC purchased a new stake in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other large investors have also recently bought and […]
January 23, 2024
Magnolia Capital Advisors LLC purchased a new position in shares of Precigen, Inc. (NASDAQ:PGEN – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 39,997 shares of the biotechnology company’s stock, valued at approximately $57,000. Other hedge funds also recently added to or reduced their stakes in the company. Emfo LLC […]